Stem Cell Therapy May Benefit Some Type 1 Infants

Stem Cell Therapy May Benefit Some Type 1 Infants

298639

Stem Cell Therapy May Benefit Some Type 1 Infants

Treatment with human fat tissue-derived mesenchymal stem cells (MSCs) may improve motor nerve cell health and survival in infants with spinal muscular atrophy (SMA) type 1, according to data from a small Phase 1 clinical trial in Iran. Notably, the stem cell treatment appeared to have effectively slowed disease progression in one of the five treated infants, who remained alive after four years — in contrast with the up-to-two-year life expectancy for untreated patients — and was…

You must be logged in to read/download the full post.